GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Usana Health Sciences Inc (NYSE:USNA) » Definitions » Cyclically Adjusted PS Ratio

USNA (Usana Health Sciences) Cyclically Adjusted PS Ratio : 0.53 (As of May. 29, 2025)


View and export this data going back to 1993. Start your Free Trial

What is Usana Health Sciences Cyclically Adjusted PS Ratio?

As of today (2025-05-29), Usana Health Sciences's current share price is $29.795. Usana Health Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $56.27. Usana Health Sciences's Cyclically Adjusted PS Ratio for today is 0.53.

The historical rank and industry rank for Usana Health Sciences's Cyclically Adjusted PS Ratio or its related term are showing as below:

USNA' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.42   Med: 2.27   Max: 4.53
Current: 0.53

During the past years, Usana Health Sciences's highest Cyclically Adjusted PS Ratio was 4.53. The lowest was 0.42. And the median was 2.27.

USNA's Cyclically Adjusted PS Ratio is ranked better than
63.49% of 1312 companies
in the Consumer Packaged Goods industry
Industry Median: 0.82 vs USNA: 0.53

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Usana Health Sciences's adjusted revenue per share data for the three months ended in Mar. 2025 was $13.075. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $56.27 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Usana Health Sciences Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Usana Health Sciences's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Usana Health Sciences Cyclically Adjusted PS Ratio Chart

Usana Health Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.01 2.26 1.06 1.01 0.65

Usana Health Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.82 0.68 0.65 0.48

Competitive Comparison of Usana Health Sciences's Cyclically Adjusted PS Ratio

For the Packaged Foods subindustry, Usana Health Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Usana Health Sciences's Cyclically Adjusted PS Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Usana Health Sciences's Cyclically Adjusted PS Ratio falls into.


;
;

Usana Health Sciences Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Usana Health Sciences's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=29.795/56.27
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Usana Health Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Usana Health Sciences's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=13.075/134.9266*134.9266
=13.075

Current CPI (Mar. 2025) = 134.9266.

Usana Health Sciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 8.818 100.684 11.817
201509 8.759 100.392 11.772
201512 8.889 99.792 12.019
201603 9.548 100.470 12.822
201606 10.375 101.688 13.766
201609 10.148 101.861 13.442
201612 10.101 101.863 13.380
201703 10.223 102.862 13.410
201706 10.275 103.349 13.414
201709 10.646 104.136 13.794
201712 11.277 104.011 14.629
201803 12.030 105.290 15.416
201806 12.136 106.317 15.402
201809 11.870 106.507 15.037
201812 12.228 105.998 15.565
201903 11.409 107.251 14.353
201906 10.955 108.070 13.678
201909 11.726 108.329 14.605
201912 12.472 108.420 15.521
202003 12.372 108.902 15.329
202006 12.258 108.767 15.206
202009 14.101 109.815 17.326
202012 14.665 109.897 18.005
202103 14.599 111.754 17.626
202106 16.474 114.631 19.391
202109 13.611 115.734 15.868
202112 13.586 117.630 15.584
202203 14.007 121.301 15.580
202206 13.743 125.017 14.832
202209 12.118 125.227 13.057
202212 11.833 125.222 12.750
202303 12.850 127.348 13.615
202306 12.261 128.729 12.851
202309 11.014 129.860 11.444
202312 11.484 129.419 11.973
202403 11.802 131.776 12.084
202406 11.111 132.554 11.310
202409 10.492 133.029 10.642
202412 11.181 133.157 11.330
202503 13.075 134.927 13.075

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Usana Health Sciences  (NYSE:USNA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Usana Health Sciences Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Usana Health Sciences's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Usana Health Sciences Business Description

Traded in Other Exchanges
Address
3838 West Parkway Boulevard, Salt Lake City, UT, USA, 84120
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
Executives
Brent Neidig officer: CO & Man. Dir. of China 3838 WEST PARKWAY BLVD., WEST VALLEY CITY UT 84120
Joshua Foukas officer: Chief Legal Officer 3838 WEST PARKWAY BLVD., SALT LAKE CITY X1 84120
John Turman Fleming director 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
David Mulham Mulham officer: Chief Field Development Office 3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Gilbert A Fuller officer: CFO and Executive V.P. 55 WANDERWOOD WAY, SANDY UT 84092
Jim Brown officer: Chief Production Officer 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Peggie Pelosi director 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84111
Paul A. Jones officer: CFO 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Myron W Wentz director 3838 W PARKWAY BLVD, SALT LAKE CITY UT 84120
G Doug Iiekking officer: VP of Finance C/O USANA HEALTH SCIENCES INC, 3838 W PARKWAY BLVD, SALT LAKE CITY UT 84120
Daniel A. Macuga officer: Chief Communications Officer 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Kevin Guest officer: E.V.P. of Marketing 3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Walter Noot officer: Chief Information Officer 3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Robert A Sinnott officer: Chief Scientific Officer 400 55 WATER STREET, VANCOUVER A1 V6B1A1
Frederic J Winssinger director 2944 N 44TH STREET, SUITE 250, PHOENIX AZ 85018